Showing results (1-10 of 1,000) with videos related to
Sort By:
Pageof 100
Handbook of Experimental Pharmacology|January 6, 2007
Contribution of targeted conditional somatic mutagenesis to deciphering retinoid X receptor functions and to generating mouse models of human diseasesD Metzger, P ChambonMethods (San Diego, Calif.)|May 1, 2001
Site- and time-specific gene targeting in the mouseD Metzger, P ChambonExperimental Cell Research|October 19, 2000
F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expressionH Chiba, P Chambon, D MetzgerThe EMBO Journal|September 1, 1990
Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifenM Berry, D Metzger, P ChambonThe European Journal of Neuroscience|February 28, 2002
Temporally controlled targeted somatic mutagenesis in the mouse brainP Weber, D Metzger, P ChambonNucleic Acids Research|March 11, 1993
Defining a minimal estrogen receptor DNA binding domainS Mader, P Chambon, J H WhiteThe EMBO Journal|July 1, 1990
Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elementsM Ponglikitmongkol, J H White, P ChambonBiochemical and Biophysical Research Communications|August 28, 1997
Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domainsR Feil, J Wagner, D Metzger, et al.The Journal of Cell Biology|November 14, 1997
Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cellsH Chiba, J Clifford, D Metzger, et al.Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995
Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinaseD Metzger, J Clifford, H Chiba, et al.Pageof 100